 |
|
|
|
"Nootropic
and smart drugs"
Several products are on the market to cope with loss of memory;
these are among the so-called "nootropic" and "smart drugs"
Here we review the most prominent. |
| |
| |
VINPOCETINE
(brand name: Cavinton) |
|
|
Vinpocetine (Cavinton) - is a preventive anti-stroke
drug. It also enhance brain blood circulation, improves
memory and hearing (tinnitus). Arteriosclerosis development
in brain is retarding. Vinpocetine improves blood
flow to the brain, makes it easier for the brain to
use glucose and oxygen, and allows the brain to survive
longer and better after periods of oxygen deprivation.
Several brain boosters (ginkgo biloba, vitamin E,
phosphatidylserine, to name just a few) are known
to help restore failing memory, but Vinpocetine dramatically
enhances memory in even healthy individuals. It also
acts as a potent neuroprotective supplement.
Clinical evidence exists that,
in addition to its brain boosting properties, Vinpocetine’s
ability to improve blood flow also helps protect brain
and heart function; prevent macular degeneration,
(a leading cause of blindness in the elderly); improve
hearing and inner ear problems; and even lessen depression
and fatigue.
|
|
| |
PIRACETAM
(brand name: Nootropil) |
|
|
Pharmacological classification: Central
Analeptics.
Action: An effect on metabolism has
been shown in man indicating improved oxygen utilisation.
NOOTROPIL has a low toxicity and has no stimulating,
sedative or neurovegitative activities. Evidence for
the global efficacy of piracetam in a diverse group
of older subjects with cognitive impairment.
|
|
| |
SELEGILINE
(brand names: Carbex, Jumex, Eldepryl) |
|
|
Eldepryl is prescribed along with Sinemet (levodopa/Carbidopa)
for people with Parkinson's disease. It is used when
Sinemet no longer seems to be working well. Eldepryl
has no effect when taken by itself; it works only
in combination with Larodopa (levodopa) or Sinemet.
Parkinson's disease, which causes muscle rigidity
and difficulty with walking and talking, involves
the progressive degeneration of a particular type
of nerve cell. Early on, Larodopa or Sinemet alone
may alleviate the symptoms of the disease. In time,
however, these medications work less well; their effectiveness
seems to switch on and off at random, and the individual
may begin to experience side effects such as involuntary
movements and "freezing" in mid-motion.
Eldepryl may be prescribed at this stage of the disease
to help restore the effectiveness of Larodopa or Sinemet.
When you begin to take Eldepryl, you may need a reduced
dosage of the other medication.
|
|
|
|
| |
|
|
|
